C/ BASE NO CPA 2023_481 - AXICABTAGENE CILOLEUCEL 0.4 - 2 X10E8 CÉLULAS DISP INJ FR 68 ML IV
TED · 622250-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Roche Farmacêutica Química, Lda. | 2 | — | 2026-10-08 |
| Takeda Farmacêuticos Portugal, Lda | 1 | €1,828,250 | 2026-07-17 |
| Cencora 3PL Portugal, S.A. | 1 | €1,435,097 | 2026-07-20 |
| Getinge Group Portuga, Unipessoal, Lda. | Iberdata Equipamentos, SA | 1 | €1,412,619 | 2026-05-21 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de AXICABTAGENE CILOLEUCEL 0.4 - 2 X10E8 CÉLULAS DISP INJ FR 68 ML IV
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-27 | 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-10-08 | C/ BASE NO CPA 2025_1303 - OCRELIZUMAB 920 MG/23 ML SOL INJ FR 23 ML SC | Unidade Local de Saúde de Coimbra, EPE PT | 94% |
| 2026-09-09 | C/ base no CPA 2023_368 - cloro-hexidina 0.2% gel bucal bisn 40 ml | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-10-08 | C/ BASE NO CPA 2025_1589 - AMIVANTAMAB 1600 MG/10 ML+AMIVANTAMAB 2240 MG | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-09-17 | C/ BASE NO CPA 2024_961 - INCLISIRAN 189 MG/ML SOL INJ SER 1.5 ML SC | Unidade Local de Saúde de Coimbra, EPE PT | 92% |
| 2026-09-14 | Com base no cpa 2025_1303 - Glofitamab - justificação clinica | Unidade Local de Saúde de Coimbra, EPE PT | 92% |